Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Market Cap	111.43B -3.0%
Revenue (ttm)	122.04B +14.7%
Net Income	9.19B +52.5%
EPS	259.23 +52.5%
Shares Out	35.26M
PE Ratio	12.19
Forward PE	n/a
Dividend	85.00 (2.59%)
Ex-Dividend Date	Sep 29, 2026

Volume	28,900
Open	3,160.00
Previous Close	3,160.00
Day's Range	3,160.00 - 3,230.00
52-Week Range	2,929.00 - 3,965.00
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatologists, psychiatry, and gastroenterological, including Realda and Collagen for the treatment of ulcerative colitis; Goofis and Movicol for the treatment of chronic constipation; interstitial pulmonary hypertension for the treatment of pulmonary arterial hypertension; Treprospermid, for pulmonary hypertension associated with ulcer...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1913
• Employees: 1,479
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4534

Financial Performance

In fiscal year 2026, Mochida Pharmaceutical's revenue was 116.95 billion, an increase of 11.21% compared to the previous year's 105.16 billion. Earnings were 7.90 billion, an increase of 39.01%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 14, 2026

Data Sources Report a data error